Solara Active Pharma Sciences Limited (NSE:SOLARA)

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Active Pharma Ingredient	12.26B
Active Pharma Ingredient Growth	-10.74%
Services	119.20M
Services Growth	130.12%
Other	505.30M
Other Growth	-21.80%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Asia Pacific	7.21B
Asia Pacific Growth	-14.82%
Europe	2.97B
Europe Growth	-10.03%
Rest of the World	1.28B
Rest of the World Growth	36.11%
North America	871.50M
North America Growth	20.96%
Global	505.30M
Global Growth	-21.80%
South America	58.30M
South America Growth	-84.32%